Vivebiotech
A GMP contract development and manufacturing organization (CDMO) specialized in Lentiviral vectors.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD7—10m (Dealroom.co estimates Dec 2022.)
Company register number B75065052
San Sebastián Basque Country (HQ)
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.1m | <1m | 2.0m | 4.5m | 6.5m | 9.5m | 10.0m |
| % growth | 11275 % | (26 %) | 150 % | 127 % | 46 % | 47 % | 5 % |
| EBITDA | <1m | (<1m) | (<1m) | <1m | 1.5m | - | - |
| % EBITDA margin | 9 % | (70 %) | (3 %) | 21 % | 22 % | - | - |
| Profit | <1m | (<1m) | (<1m) | <1m | <1m | - | - |
| % profit margin | 7 % | (54 %) | (14 %) | 12 % | 14 % | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Support Program | ||
* | N/A | €1.0m | Early VC |
* | €3.5m | Early VC | |
* | $120k | Late VC | |
N/A | Support Program | ||
* | €1.1m | Seed | |
| Total Funding | CAD8.6m | ||
Related Content
Recent News about Vivebiotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.